Funds holding ACRIVON THERAPEUTICS INC
ISIN US0048901096 · United States
- Fund holders
- 16
- Of which ETFs
- 1 15 other funds
- Value held
- ≈ 3.4M $ 2.8M $ · 537.2K €
- Share of capital
- 3.7 % of 42.9M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 545,541 | 971.1K $ | 1.27 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 389,575 | 693.4K $ | 0.00 % | 0.91 % | as of Jun 30, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 316,000 | 562.5K $ | 0.57 % | 0.74 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 111,335 | 178.1K $ | 0.00 % | 0.26 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 73,869 | 131.5K $ | 0.01 % | 0.17 % | as of Jun 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 58,000 | 103.2K $ | 0.07 % | 0.14 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 27,696 | 44.3K $ | 0.06 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 24,809 | 39.7K $ | 0.06 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 18,053 | 28.9K $ | 0.00 % | 0.04 % | as of May 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 16,892 | 30.1K $ | 0.04 % | as of Jun 30, 2026 ↗ | |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 4,941 | 8.8K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 2,500 | 4.5K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 937 | 1.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 115 | 172.5 $ | 0.00 % | as of Jul 31, 2026 ↗ | |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 398.8K € | 1.07 % | as of Dec 31, 2025 ↗ | ||
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 138.4K € | 0.17 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 1.07 % | as of Dec 31, 2025 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.57 % | as of Jun 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.17 % | as of Dec 31, 2025 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.07 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 14 | +1 | 1,590,263 | +43.8 % |
| 2026Q2 | 13 | -3 | 1,106,072 | +26.8 % |
| 2026Q1 | 16 | -1 | 872,161 | -5.3 % |
| 2025Q4 | 17 | -22 | 921,295 | -20.6 % |
| 2025Q3 | 39 | -45 | 1,159,792 | -38.5 % |
| 2025Q2 | 84 | +6 | 1,884,595 | +0.2 % |
| 2025Q1 | 78 | -3 | 1,880,000 | +5.4 % |
| 2024Q4 | 81 | +10 | 1,783,117 | +5.1 % |
| 2024Q3 | 71 | +4 | 1,697,046 | +26.0 % |
| 2024Q2 | 67 | +1 | 1,347,293 | -0.8 % |
| 2024Q1 | 66 | -5 | 1,357,484 | +3.3 % |
| 2023Q4 | 71 | 1,314,484 |
Institutional managers
40 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8,340,508 | 11.6M $ | as of Mar 31, 2026 |
| Sands Capital Alternatives, LLC | 2,122,605 | 3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 888,130 | 1.2M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 845,973 | 1.2K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 758,440 | 1.1M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 560,436 | 779K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 389,395 | 541.3K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 239,691 | 333.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 236,391 | 328.7K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 208,939 | 290.4K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 186,716 | 260 $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,900 | 220.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 67,145 | 93.3K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 66,882 | 93K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 48,902 | 68K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 36,671 | 51K $ | as of Mar 31, 2026 |
| UBS Group AG | 34,634 | 48.1K $ | as of Mar 31, 2026 |
| PANAGORA ASSET MANAGEMENT INC | 33,814 | 47K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 27,472 | 38.2K $ | as of Mar 31, 2026 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,015 | 33.4K $ | as of Mar 31, 2026 |
| Marex Group plc | 20,000 | 27.8K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 18,364 | 25.4K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 16,513 | 23K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 14,742 | 20.5K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 11,679 | 16.2K $ | as of Mar 31, 2026 |
Declared shareholders of ACRIVON THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Sands Capital Life Sciences Pulse Fund II, L.P. and 2 others | 5.30 % | 2,289,271 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ACRIVON THERAPEUTICS INC". https://titelia.com/en/stocks/acrivon-therapeutics-inc-US0048901096